洞察市场格局
解锁药品研发情报

免费客服电话

18983288589
试用企业版

【ChiCTR1900026245】The role of extended antral resection on weight loss and metabolic response after sleeve gastrectomy: a retrospective cohort study

基本信息
登记号

ChiCTR1900026245

试验状态

结束

药物名称

/

药物类型

/

规范名称

/

首次公示信息日的期

2019-09-28

临床申请受理号

/

靶点

/

适应症

obesity surgery

试验通俗题目

The role of extended antral resection on weight loss and metabolic response after sleeve gastrectomy: a retrospective cohort study

试验专业题目

The role of extended antral resection on weight loss and metabolic response after sleeve gastrectomy: a retrospective cohort study

申办单位信息
申请人联系人
申请人名称
联系人邮箱
联系人邮编

41900

联系人通讯地址
临床试验信息
试验目的

LSG was initially designed as the first step of a two-staged bariatric procedure. However, in the following years, LSG was found as effective as other bariatric procedures and has become increasingly popular as a stand-alone bariatric procedure [1,2]. Recently, LSG is the most performed bariatric procedure worldwide [3]. The simplicity of surgical technique, preservation of the pyloric functions, none development of marginal ulcers or internal herniation, less need of trace element and vitamin supplementation are the advantages of LSG over other bariatric procedures [4-6]. However, debate continues regarding the AR or AP on effective weight loss alterations and metabolic response. Further, the distance from pylorus at which the stomach division should be started is still not standardized and has been reported varying from 2 to 8cm [7-9]. The aim of the present retrospective cohort study was to determine whether AR is superior to AP regarding weight loss and resolution of co-morbidities.

试验分类
试验类型

队列研究

试验分期

回顾性研究

随机化

N/A

盲法

N/A

试验项目经费来源

not funding

试验范围

/

目标入组人数

43;68

实际入组人数

/

第一例入组时间

2016-01-01

试验终止时间

2018-06-30

是否属于一致性

/

入选标准

Patients with BMI > 40 were included.;

排除标准

Patients with a history of previous bariatric surgery and patients who did not attend regular follow-up visits (first, 6th and 12 month) are excluded.;

研究者信息
研究负责人姓名
试验机构

not sponsored

研究负责人电话
研究负责人邮箱
研究负责人邮编

41900

联系人通讯地址
<END>

最新临床资讯

对摩熵医药数据库感兴趣,可以免费体验产品